Analysis of Therapeutic Management Strategies for Anal Suppurations of Crohn's Disease
3T-LAP
1 other identifier
observational
440
1 country
1
Brief Summary
Determine the optimal therapeutic combination associated with complete clinical and anatomical remission of anal suppurations of Crohn's disease at 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 5, 2019
CompletedFirst Posted
Study publicly available on registry
December 10, 2019
CompletedStudy Start
First participant enrolled
February 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 3, 2028
ExpectedApril 12, 2023
April 1, 2023
5.5 years
December 5, 2019
April 11, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical and anatomical healing
The healing of anal fistula is defined by the combination of two criteria at 12 months : * MRI criteria = absence of a T2 hyper signal from the path(s) AND the absence of an abscess AND * Complete clinical response = no pain, no discharge, and no drain
12 months.
Interventions
surgical drainage and/or surgical reconstruction procedures to anoperineal suppurations according to the doctor's decision
Eligibility Criteria
Person suffering from anal suppuration related to Crohn's Disease
You may qualify if:
- Persons over 18 years of age
- People suffering from anal suppuration of Crohn's disease for whom a drainage procedure is planned.
- Person who has received written and oral information about the protocol and has not expressed opposition to participate in the study.
You may not qualify if:
- No one who is unable to have an anesthetic, structural or psychological examination by MRI and/or surgery.
- Person planning a planned absence that could hinder participation in the research (travel abroad, relocation, impending transfer);
- Person with an associated pathology that is a priority for care;
- Vulnerable person (minors, persons under guardianship or curatorship, or deprived of their liberty by a judicial or administrative decision
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier de Rennes
Rennes, 35000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laurent SIPROUDHIS, PH-PD
Rennes University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 5, 2019
First Posted
December 10, 2019
Study Start
February 3, 2020
Primary Completion
August 3, 2025
Study Completion (Estimated)
August 3, 2028
Last Updated
April 12, 2023
Record last verified: 2023-04